Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. - Wikidata - awgldk - TriplyDB

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

http://www.wikidata.org/entity/Q36991412

about

Interventions for rosacea The role of brimonidine tartrate gel in the treatment of rosacea Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies Skin barrier in rosacea Rosacea: a Clinical Review Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments Roles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin Diseases Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features Acne and Rosacea.[Dermatological diseases and their importance for psychiatry].Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations.Rosacea: new and emerging treatments.Management of cutaneous rosacea: emphasis on new medical therapies.Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments.Rosacea under the microscope: characteristic histological findings.A study on the epidemiology of rosacea in the U.K.Comparative efficacy of intense pulsed light for different erythema associated with rosacea.Update on the management of rosacea.Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema Corneal and conjunctival sensitivity in rosacea patients.Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.Prevalence of rosacea in the general population of Germany and Russia - The RISE study.Clinical characteristics and epidermal barrier function of papulopustular rosacea: A comparison study with acne vulgaris.Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit Rosacea Subtypes Visually and Optically Distinct When Viewed with Parallel-Polarized Imaging Technique.Proteases and proteomics: cutting to the core of human skin pathologies.Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.New and Emerging Treatments for Rosacea.Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study.The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea.

P2860

Q24186383-9A44035F-52D8-4678-9831-2507C0AE5ABF Q26777249-603D13D3-E6CE-4963-9881-B790F14743E4 Q26783346-3C61AE62-BA49-4861-B9C6-A25717CE2CD3 Q28069342-E5A6E1CD-57BF-4DD9-97E9-744FC3875458 Q28069553-8A8F7D41-A05A-46D5-B242-590DD6231AFD Q28072685-518100A6-9EFE-4FF8-982F-081E0CD746DD Q28074548-577E431B-1909-490F-ABAC-79F2B61C6F5B Q28077384-DA3511E2-01B5-4D20-A6F7-ECD7731602EB Q28077479-A116310E-2345-4BB1-AB47-06D53189B5FB Q30238647-7A91168A-CBB8-484C-B94D-68C2AB9A3AFE Q30251786-93FC50AF-8668-410B-B6D8-0DFF06B8443A Q33652868-0C123AD6-7373-4821-AAB6-50A802C6E7BE Q33885522-EB85D652-449E-4529-B3CD-35859820A289 Q34434971-E8B3D3E8-0543-4766-AD6E-8C312292E37D Q34436744-4738327D-B3C5-49A0-938E-F383B18C7939 Q34481841-ED57784F-42C2-4EB0-AB62-10CDF0C71043 Q34604071-F3F8C7EF-2BA4-40FE-8208-91AD3E41EA63 Q34638049-8F7DD8F0-BD4E-485D-8244-8CC2C725B16C Q35230579-CEA01E7A-CE76-4BAB-8AE6-CB0F537C930A Q35410266-6D2D9B05-31FF-4066-BE58-AE8FD54E49A2 Q35834762-8D728C67-532E-4D18-AA0C-722BD2EA0776 Q35862102-36C6D7AC-EB90-4FFA-9269-85E5453F71BB Q35862114-AE58A30D-4A01-4478-8B81-FC770CC3E5C0 Q36595369-D509E7DB-084F-467B-A73F-F3B04DF6EE66 Q36992055-C640DDA5-F85E-453C-B7F7-CE12B446D466 Q37013298-AD5A80D8-80A0-426C-B449-358465781348 Q37345707-C7A41606-AE71-48AE-BA99-8AB1A5527724 Q37563077-1EB31151-B3D7-41AF-93DE-8310DE207759 Q37595472-6FC706C4-900F-48CC-B312-22F6332A8FAD Q37740706-449ABFBA-C6AF-496F-91D0-1ACB70236EA8 Q38200069-DEB48353-A262-4F5E-BA7E-C87BF53E1BBB Q38236823-9C4B1333-7161-4F77-B13F-C09A3546DAC8 Q38591328-09EC9A8B-1749-4D59-B452-3881BCC93BEC Q38663455-D7294384-E2AF-4F19-8AFF-E2FAA72CFC98 Q38885566-3148201A-05EF-4133-9E42-EDBB0CFD3D8E Q40158595-22C334E0-E5E5-43FE-9081-D32D98E2216F Q42045644-15FA55B1-CD2C-43E3-9CF0-85C59097660B Q42230578-969F87A8-7965-4659-A776-B6B3ED8A30FC Q42368921-27837A31-AAAB-4F66-A851-BC896CC43B36 Q43793565-52063BA6-37BC-492A-93F3-E3C608221B19

P2860

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

http://www.wikidata.org/entity/Q36991412

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

@en

type

label

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

@en

prefLabel

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

@en

P1433

Q36991412-B52015BC-FD1A-46CA-BE3F-870450BF8D7B

P1476

Q36991412-A25CE9BB-161E-451D-A807-AD872C1B95C2

P2093

Q36991412-1214FFEC-591C-4AC7-A02E-108AAC5B7520

Q36991412-13F8F53B-DF9A-48DE-A396-7FF80668BD69

Q36991412-24B6635C-F177-4552-97C8-8727C171E413

Q36991412-46B3139C-CC69-4948-8494-9C0DCB5BCD44

Q36991412-545E599B-E457-43B9-8D11-18BE0E8A21DB

Q36991412-6FF7BD6D-BEEF-4F0F-9998-AB508F050221

Q36991412-7D5CD6CC-76F1-40C1-8A9B-4904D5828370

Q36991412-7E135B00-8EE3-47B5-B85A-996071D37AE3

Q36991412-9AECBB48-9C53-4403-A003-BBCEE954E1E8

Q36991412-A1B9CF07-B189-48CD-9532-FFF46D4EC2D3

P2860

Q36991412-03EA13B7-D487-46BB-A6CD-18EC519DB717

Q36991412-0564AE60-CB59-47DE-A6A0-47EF20313A93

Q36991412-09D095F0-73CB-428F-89C4-739303947495

Q36991412-0F78033F-FD09-4E8D-B2F4-CCBC93E30D26

Q36991412-0FADDEA7-55A9-40E9-BDB2-7E5821A62F30

Q36991412-12E5BCF9-7F48-4939-94E8-8DF364B7B20E

Q36991412-13309F77-98E6-4866-8B6D-63EBA44CDA32

Q36991412-1342AFFA-C9AA-4486-B8BE-E3DB6C6E200D

Q36991412-1596CD09-F4F4-4E3D-8C99-9B35E897E543

Q36991412-1C9AD716-4511-44A8-A92F-6EC3880AAF51

P2888

Q36991412-BDC1959D-9F95-479A-BAAA-CBF5ACFBC834

P304

Q36991412-43068847-E99B-460E-90A5-5A87B8AD54AF

P31

Q36991412-1900CA0C-7DF4-4CC4-81EE-A607A76BC147

P356

Q36991412-599F375C-F017-4EEE-B446-AE0DF66AC8C0

P433

Q36991412-B8554044-C562-4F84-B22A-7904C9928624

P478

Q36991412-5B4094A1-801E-481E-B21B-23CE1F0FBDCF

P50

Q36991412-57556B76-C884-438B-AF41-6C90CE87CE07

P577

Q36991412-16261B70-9A25-4A8C-83D0-D96786424901

P5875

Q36991412-E2075931-A62D-4AD9-A8E7-63BD1DE7108D

P698

Q36991412-E39F6FA0-FBEC-4B45-84A5-530706CEB6DE

P921

Q36991412-3B074E36-6A6A-42C3-81A1-76895745FBF5

P932

Q36991412-FFA7281D-1E5C-4E19-8664-E04973618D2C

P356

P1433

The journal of investigative dermatology. the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research. Symposium proceedings /

P1476

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea

@en

P2093

Carine Rosignoli

http://www.w3.org/2001/XMLSchema#string

Christian Mess

http://www.w3.org/2001/XMLSchema#string

Dieter Metze

http://www.w3.org/2001/XMLSchema#string

Ferda Cevikbas

http://www.w3.org/2001/XMLSchema#string

Isabelle Carlavan

http://www.w3.org/2001/XMLSchema#string

Jerome Aubert

http://www.w3.org/2001/XMLSchema#string

Johannes J Voegel

http://www.w3.org/2001/XMLSchema#string

Jörg Buddenkotte

http://www.w3.org/2001/XMLSchema#string

Mathias Sulk

http://www.w3.org/2001/XMLSchema#string

Michel Rivier

http://www.w3.org/2001/XMLSchema#string

P2860

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Rosacea: The cytokine and chemokine network

Rosacea as a disease of cathelicidins and skin innate immunity

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

Developmental expression of δ-opioid receptors during maturation of the parasympathetic, sympathetic, and sensory innervations of the neonatal heart: early targets for opioid regulation of autonomic control

Mite-related bacterial antigens stimulate inflammatory cells in rosacea.

Capsaicin induces degeneration of cutaneous autonomic nerve fibers.

4-oxo-2-nonenal (4-ONE): evidence of transient receptor potential ankyrin 1-dependent and -independent nociceptive and vasoactive responses in vivo.

P2888

P304

2-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JIDSYMP.2011.7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Martin Steinhoff

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51792104

http://www.w3.org/2001/XMLSchema#string

P698

22076321

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

3704130

http://www.w3.org/2001/XMLSchema#string